Overview: Detailed, up-to-date information is provided on all relevant aspects of pulmonary involvement in patients with hematological malignancies.Leading experts discuss epidemiology, diagnostic strategy, lunThe number of patients treated for hematological malignancies is increasing steadily. To maximize cure rates, aggressive treatments have been introduced, including high-dose chemotherapy, stem cell transplantation, and targeted therapies. As a result, overall and disease-free survival rates have improved substantially, but at the price of life-threatening toxic and infectious complicatio
|